Harry J. de Koning
About
Harry J. de Koning is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, Harry J. de Koning has authored 548 papers receiving a total of 24.3k indexed citations (citations by other indexed papers that have themselves been cited), including 295 papers in Oncology, 255 papers in Pulmonary and Respiratory Medicine and 91 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Harry J. de Koning's work include Global Cancer Incidence and Screening (243 papers), Colorectal Cancer Screening and Detection (145 papers) and Lung Cancer Diagnosis and Treatment (123 papers). Harry J. de Koning is often cited by papers focused on Global Cancer Incidence and Screening (243 papers), Colorectal Cancer Screening and Detection (145 papers) and Lung Cancer Diagnosis and Treatment (123 papers). Harry J. de Koning collaborates with scholars based in Netherlands, United States and United Kingdom. Harry J. de Koning's co-authors include Matthijs Oudkerk, Gerrit Draisma, Rob Boer, Kevin ten Haaf, Eveline A.M. Heijnsdijk, Fritz H. Schröder, Marie‐Louise Essink‐Bot, Jacques Fracheboud, Carlijn M. van der Aalst and Willem P.Th.M. Mali and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.
In The Last Decade
Harry J. de Koning
531 papers receiving 23.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Harry J. de Koning Netherlands | 79 | 12.0k | 10.3k | 5.7k | 2.9k | 2.5k | 548 | 24.3k | ||
| Karla Kerlikowske United States | 81 | 6.5k 0.5× | 11.9k 1.2× | 4.2k 0.7× | 4.9k 1.7× | 1.3k 0.5× | 367 | 22.8k | ||
| Mahesh Parmar United Kingdom | 71 | 11.0k 0.9× | 8.3k 0.8× | 2.8k 0.5× | 2.4k 0.8× | 6.7k 2.7× | 299 | 27.0k | ||
| Ruth Etzioni United States | 58 | 7.8k 0.7× | 7.9k 0.8× | 1.3k 0.2× | 2.2k 0.8× | 2.3k 0.9× | 248 | 18.3k | ||
| Jiemin Ma United States | 36 | 5.5k 0.5× | 9.9k 1.0× | 1.8k 0.3× | 5.4k 1.9× | 2.8k 1.2× | 71 | 24.4k | ||
| Geertruida H. de Bock Netherlands | 65 | 4.3k 0.4× | 5.9k 0.6× | 2.9k 0.5× | 3.0k 1.1× | 3.4k 1.4× | 650 | 18.7k | ||
| Stacey A. Fedewa United States | 59 | 6.1k 0.5× | 13.3k 1.3× | 1.4k 0.3× | 4.1k 1.4× | 3.4k 1.4× | 167 | 24.8k | ||
| H. Gilbert Welch United States | 66 | 5.9k 0.5× | 7.6k 0.7× | 1.8k 0.3× | 1.8k 0.6× | 7.5k 3.0× | 176 | 24.3k | ||
| Julie R. Gralow United States | 68 | 4.2k 0.3× | 12.5k 1.2× | 4.6k 0.8× | 5.5k 1.9× | 1.0k 0.4× | 283 | 20.4k | ||
| Mark R. Somerfield United States | 70 | 6.2k 0.5× | 13.4k 1.3× | 2.2k 0.4× | 6.9k 2.4× | 4.8k 1.9× | 141 | 27.5k | ||
| Lynn A. G. Ries United States | 56 | 6.6k 0.6× | 13.0k 1.3× | 1.4k 0.2× | 3.6k 1.3× | 3.7k 1.5× | 81 | 26.7k |
Countries citing papers authored by Harry J. de Koning
Since
Specialization
Citations
This map shows the geographic impact of Harry J. de Koning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry J. de Koning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry J. de Koning more than expected).
Fields of papers citing papers by Harry J. de Koning
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Harry J. de Koning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry J. de Koning. The network helps show where Harry J. de Koning may publish in the future.
Co-authorship network of co-authors of Harry J. de Koning
This figure shows the co-authorship network connecting the top 25 collaborators of Harry J. de Koning. A scholar is included among the top collaborators of Harry J. de Koning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry J. de Koning. Harry J. de Koning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Koning, Harry J. de, et al.. (2025). Clinical and economic impact of genome-wide non-invasive prenatal testing (NIPT) as a first-tier screening method compared to targeted NIPT and first-trimester combined testing: A modeling study. PLoS Medicine. 22(11). e1004790–e1004790.
2.
Sheridan, B., Eveline A.M. Heijnsdijk, Nadya Dimitrova, et al.. (2025). Prioritizing performance and outcome indicators for quality assessment of cancer screening programs in the EU. Public Health. 239. 185–192.
3.
Koning, Harry J. de, Marleen Vonder, Jan W. Gratama, et al.. (2024). Short-term impact of cardiovascular screening by traditional risk assessment or coronary artery calcium score on health-related quality of life: the ROBINSCA trial. European Heart Journal Open. 4(5). oeae080–oeae080.
4.
Heuvelmans, Marjolein A., Carlijn M. van der Aalst, Sytse F. Oudkerk, et al.. (2024). Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: impact on negative-misclassifications and clinical referral rate. European Journal of Cancer. 216. 115214–115214.
5.
Pundziūtė, Gabija, Carlijn M. van der Aalst, Jan W. Gratama, et al.. (2022). Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial. American Heart Journal. 246. 166–177.
6.
Zielonke, N., Eveline A.M. Heijnsdijk, Sirpa Heinävaara, et al.. (2021). Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios. Cancers. 13(13). 3360–3360.
7.
Csanádi, Marcell, Eveline A.M. Heijnsdijk, Ahti Anttila, et al.. (2019). Key indicators of organized cancer screening programs: Results from a Delphi study. Journal of Medical Screening. 26(3). 120–126.
8.
Meulen, Miriam P. van der, Monique E. van Leerdam, Ernst J. Kuipers, et al.. (2017). Do Men and Women Need to Be Screened Differently with Fecal Immunochemical Testing? A Cost-Effectiveness Analysis. Cancer Epidemiology Biomarkers & Prevention. 26(8). 1328–1336.
9.
VanDuijn, Martijn M., Christoph Stingl, Lennard J. M. Dekker, et al.. (2016). Survivin Autoantibodies Are Not Elevated in Lung Cancer When Assayed Controlling for Specificity and Smoking Status. Cancer Immunology Research. 4(2). 165–172.
10.
Oudkerk, Sytse F., Constantinus F. M. Buckens, Willem P.Th.M. Mali, et al.. (2016). Diffuse Idiopathic Skeletal Hyperostosis Is Associated with Lower Lung Volumes in Current and Former Smokers. American Journal of Respiratory and Critical Care Medicine. 194(2). 241–242.
11.
Willemink, Martin J., Richard A. P. Takx, Ivana Išgum, et al.. (2015). Prognostic value of heart valve calcifications for cardiovascular events in a lung cancer screening population. International journal of cardiac imaging. 31(6). 1243–1249.
12.
Haaf, Kevin ten, Joost van Rosmalen, & Harry J. de Koning. (2014). Lung Cancer Detectability by Test, Histology, Stage, and Gender: Estimates from the NLST and the PLCO Trials. Cancer Epidemiology Biomarkers & Prevention. 24(1). 154–161.
13.
Hoesein, Firdaus A. A. Mohamed, Pim A. de Jong, Jan‐Willem J. Lammers, et al.. (2014). Contribution of CT Quantified Emphysema, Air Trapping and Airway Wall Thickness on Pulmonary Function in Male Smokers With and Without COPD. COPD Journal of Chronic Obstructive Pulmonary Disease. 11(5). 503–509.
14.
Mets, Onno M., Michael A. Schmidt, Constantinus F. M. Buckens, et al.. (2013). Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening. Respiratory Research. 14(1). 59–59.
15.
Horeweg, Nanda, Carlijn M. van der Aalst, Erik Thunnissen, et al.. (2013). Characteristics of Lung Cancers Detected by Computer Tomography Screening in the Randomized NELSON Trial. American Journal of Respiratory and Critical Care Medicine. 187(8). 848–854.
16.
Gulati, Roman, Elisabeth M. Wever, Alex Tsodikov, et al.. (2011). What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models. Cancer Epidemiology Biomarkers & Prevention. 20(5). 740–750.
17.
Wever, Elisabeth M., Gerrit Draisma, Eveline A.M. Heijnsdijk, & Harry J. de Koning. (2011). How Does Early Detection by Screening Affect Disease Progression?. Medical Decision Making. 31(4). 550–558.
18.
Fransen, Mirjam P., Johan P. Mackenbach, Eric A.P. Steegers, et al.. (2010). Ethnic differences in participation in prenatal screening for Down syndrome: A register‐based study. Prenatal Diagnosis. 30(10). 988–994.
19.
Aro, Arja R., Harry J. de Koning, Marjut Schreck, et al.. (2005). Psychological risk factors of incidence of breast cancer: a prospective cohort study in Finland. Psychological Medicine. 35(10). 1515–1521.
20.
Koning, Harry J. de, J.W.W. Coebergh, & J.A. van Dongen. (1996). Current controversies in cancer : Is mass screening for breast cancer cost-effective ? Pro, contra and arbiter. European Journal of Cancer. 32(11). 1835–1839.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Karla Kerlikowske Breakdown of academic impact, for papers by Mahesh Parmar Breakdown of academic impact, for papers by Ruth Etzioni Breakdown of academic impact, for papers by Jiemin Ma Breakdown of academic impact, for papers by Geertruida H. de Bock Breakdown of academic impact, for papers by Stacey A. Fedewa Breakdown of academic impact, for papers by H. Gilbert Welch Breakdown of academic impact, for papers by Julie R. Gralow Breakdown of academic impact, for papers by Mark R. Somerfield Breakdown of academic impact, for papers by Lynn A. G. Ries